Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes per Geron website, dated 10-10-2019

Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes per Geron website, dated 10-10-2019 (http://ir.geron.com/news-releases/news-release-details/geron-announces-first-patient-dosed-imerge-phase-3-clinical; obtained…

Read more